Tissue Analytics has closed a $5 million Series A round following the expansion of the Baltimore-based wound care monitoring business to Kansas City and plans to add 25 new staff, according to Baltimore Business Journal
DigiTx Partners, a private equity firm launched by Astellas Pharma and MPM Capital, led the round. Other participants included Chinese investment firm Tencent, Dreamit, Swedish medical device company Mölnlycke Health Care, Utah health care system Intermountain Healthcare and Penn Medicine.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Kevin Keenahan, Tissue Analytics cofounder and CEO, told Baltimore Business Journal he funding would be used to build a salesforce around the Kansas City office and hire data analytics personnel at the Baltimore hq.
The expansion to Kansas City follows a decision to join Cerner’s Open Development Experience, which gives third-party developers the ability to build applications that can work with its electronic health record systems.
Clinicians use Tissue Analytics’ app to clinicians take pictures of a wound. Data on the wound’s shape and color are recorded and stored in the cloud so they can be easily accessed later.
Earlier this month, Tissue Analytics entered an agreement with Mölnlycke to jointly develop and commercialize digital solutions for wound care physicians, including clinical decision support tools to standardize wound assessment and treatment.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Photo: StockFinland, Getty Images
